perphenazine enanthate: structure in Negwer, 5th ed, #5682 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 62871 |
| MeSH ID | M0092045 |
| Synonym |
|---|
| perphenazine enanthate |
| 2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl heptanoate |
| D08342 |
| perphenazine enantate |
| 17528-28-8 |
| unii-z6rs3dkn8j |
| 2-(4-(3-(2-chloro-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethyl heptanoate |
| z6rs3dkn8j , |
| einecs 241-529-9 |
| 2-(4-(3-(2-chlorophenothiazin-10-yl)propyl)piperazin-1-yl)ethanol, heptanoate |
| perphenazine enantate [mart.] |
| perphenazine enantate [who-dd] |
| DTXSID40169963 |
| 2-[4-[3-(2-chloro-10h-phenothiazin-10-yl)propyl]piperazin-1-yl]ethyl heptanoate |
| DB14651 |
| Q27295080 |
Perphenazine enanthate did not cause inappetence, reduced appetite, or any of the previously mentioned side effects when used alone.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Perphenazine enanthate was used to allow adaptation to captivity in 11 Pyrenean chamois (Rupicapra pyrenaica). " | ( Effect of perphenazine enanthate in Pyrenean chamois (Rupicapra pyrenaica). Cabezón, O; Casas-Díaz, E; Fernandez-Aguilar, X; Fernández-Sirera, L; Lavín, S; López-Olvera, JR; Manteca, X; Marco, I; Mentaberre, G; Navarro-Gonzalez, N; Serrano, E, 2013) | 2.23 |
| "Perphenazine enanthate did not cause inappetence, reduced appetite, or any of the previously mentioned side effects when used alone." | ( Evaluation of long-term sedation in cheetah (Acinonyx jubatus) with perphenazine enanthate and zuclopenthixol acetate. Huber, C; Slotta-Bachmayr, L; Walzer, C, 2001) | 1.27 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dosage and intervals between injections were on an individual basis." | ( Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications. Hansen, LB; Knudsen, P; Larsen, NE, 1985) | 0.54 |
| " This dosage should be varied depending on health, age, and temperament of the individual cheetah." | ( Evaluation of long-term sedation in cheetah (Acinonyx jubatus) with perphenazine enanthate and zuclopenthixol acetate. Huber, C; Slotta-Bachmayr, L; Walzer, C, 2001) | 0.55 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.39) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (22.22%) | 6.00% |
| Case Studies | 1 (11.11%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (66.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||